Minority racial and ethnic groups in the US have long experienced disparities in access to health care and worse health outcomes, undermining broader social, political, and economic equality. One component of these disparities are various stereotypes that affect how minority patients are perceived and treated. This session will explore how medical discourse and the health system it supports can be altered to address these harms, and how legal changes can improve outcomes in the future.
Introduction: Carmel Shachar, Executive Director, The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School
Evelynn Hammonds, Chair, Department of the History of Science; Barbara Gutmann Rosenkrantz Professor of the History of Science; Professor of African and African American Studies
Craig Connoth, Associate Professor of Law and Director, Health Law Certificate, University of Colorado Law School
Moderator: Michelle Morse, Hospitalist, Brigham and Women’s Hospital; Assistant Professor, Harvard Medical School; Robert Wood Johnson Foundation Health Policy Fellow; Founding Co-Director, EqualHealth
The Health Policy and Bioethics Consortia is a monthly series that convenes two international experts from different fields or vantage points to discuss how biomedical innovation and health care delivery are affected by various ethical norms, laws, and regulations.
They are organized by the Harvard Medical School Center for Bioethics and the Program on Regulation, Therapeutics, and Law (PORTAL) at Brigham and Women’s Hospital, in collaboration with the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Support provided by the Oswald DeN. Cammann Fund at Harvard University.